Nicorandil Prolongs Survival in Mice with Heart Disease
Author Information
Author(s): Sanbe Atsushi, Marunouchi Tetsuro, Yamauchi Junji, Tanonaka Kouichi, Nishigori Hideo, Tanoue Akito
Primary Institution: Iwate Medical University
Hypothesis
Does nicorandil protect against mitochondrial dysfunction and apoptosis in HSPB5 R120G transgenic mice?
Conclusion
Nicorandil may prolong survival in HSPB5 R120G transgenic mice by protecting against mitochondrial impairments.
Supporting Evidence
- Nicorandil treatment reduced mitochondrial impairment in mice.
- Apoptotic cell death was inhibited by nicorandil in cardiomyocytes.
- Survival rates improved in R120G transgenic mice treated with nicorandil.
- Nicorandil blocked the release of cytochrome c from mitochondria.
- Alterations in BCL2 and BAX levels were observed with nicorandil treatment.
Takeaway
Nicorandil is a medicine that helps mice with heart problems live longer by protecting their heart cells from damage.
Methodology
The study involved treating HSPB5 R120G transgenic mice with nicorandil and analyzing its effects on mitochondrial function and apoptosis.
Potential Biases
Potential bias due to funding from a pharmaceutical company involved in the study.
Limitations
The study primarily focused on a specific mouse model and may not directly translate to human conditions.
Participant Demographics
HSPB5 R120G transgenic mice were used in the study.
Statistical Information
P-Value
p<0.05
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website